» Articles » PMID: 33844574

Pulmonary Hypertension

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2021 Apr 12
PMID 33844574
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary hypertension is the term used to describe a group of disorders characterized by abnormally high pressures in the pulmonary arteries. Initial evaluation is focused on identifying the cause, which helps guide appropriate treatment. Pulmonary hypertension is often a feature of advanced common diseases, such as chronic obstructive pulmonary disease and left heart disease, and treatment is focused primarily on the underlying disease. More rarely, pulmonary hypertension results from chronic organized thromboemboli or a primary vasculopathy. The former requires evaluation for surgical intervention, and the latter is treated with advanced medical therapies.

Citing Articles

Right heart dysfunction does not increase mortality associated with cemented hemiarthroplasty for hip fractures: A retrospective, preliminary analysis.

Coscia A, Kumar A, Jandzinski M, Swany L, Fuster F, Ahn J PLoS One. 2025; 20(2):e0318993.

PMID: 40009588 PMC: 11864553. DOI: 10.1371/journal.pone.0318993.


Triangular Causality Among Pulmonary Hypertension, Sleep Disorders, and Brain Structure at the Genetic Level: A Mendelian Randomization Study Focused on the Lung-Brain Axis.

Zhang C, Su X, Zhang Y, He P, Kong X, Zhang Z Nat Sci Sleep. 2025; 17:343-356.

PMID: 40008303 PMC: 11853869. DOI: 10.2147/NSS.S495071.


Prognosis of pulmonary hypertension in patients with hypertrophic cardiomyopathy: A multicenter propensity score matching study.

Ma H, Xu F, Liu L, Kong H, Luo R, Liu M Int J Cardiol Heart Vasc. 2025; 56:101605.

PMID: 39897413 PMC: 11783049. DOI: 10.1016/j.ijcha.2025.101605.


Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases.

Liu Y, Wang C, Li M, Zhu Y, Liu K, Liu Y Front Pharmacol. 2025; 15:1507194.

PMID: 39759448 PMC: 11695318. DOI: 10.3389/fphar.2024.1507194.


RO4929097 inhibits NICD3 to alleviate pulmonary hypertension via blocking Notch3/HIF-2α/FoxM1 signaling pathway.

Zhu H, Li C, Hu F, Wu L, Wu L, Zhou M In Vitro Cell Dev Biol Anim. 2024; 61(1):107-116.

PMID: 39621175 DOI: 10.1007/s11626-024-00976-2.